Literature DB >> 36061488

The Significance of Pain Drawing as a Screening Tool for Cervicogenic Headache and Associated Symptoms in Chronic Fatigue.

Gabriella Bernhoff1,2, Helena M Huhmar2, Eva Rasmussen-Barr3, Lina Bunketorp Käll4,5.   

Abstract

Purpose: Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) present with a broad spectrum of symptoms, including headache. A simple, yet powerful tool - the pain drawing identifies essential aspects such as pain distribution. The aim with this study was to 1) evaluate the significance of pain drawing as a screening tool for cervicogenic headache using a predefined C2 pain pattern, 2) assess whether there was an association between dizziness/imbalance and a C2 pain pattern, and 3) compare subgroups according to the pain drawing with respect to pain characteristics and quality of life. Patients and
Methods: Pain drawings and clinical data from 275 patients investigated for ME/CFS were stratified into: 1) cervicogenic headache as determined by a C2 pain pattern, 2) headache with no C2 pain pattern, and 3) no headache. For inference logistic regression presented with odds ratios (OR) and 95% confidence intervals (95% CI) and Kruskal-Wallis test were applied.
Results: One hundred sixteen participants (42%) were stratified to the group for which the pain drawing corresponded to the C2 pain pattern, thus indicating putative cervicogenic origin of the headache. Dizziness/imbalance was strongly associated with a C2 pain pattern; OR 6.50 ([95% CI 2.42-17.40] p ˂ 0.00), whereas this association was non-significant for patients with headache and no C2 pain pattern. Those demonstrating a C2 pain pattern reported significantly higher pain intensity (p = 0.00) and greater pain extent (p = 0.00) than the other groups, and lower health-related quality of life (p = 0.00) than the group with no headache.
Conclusion: For patients with chronic fatigue who present with a C2 pain pattern (interpreted as cervicogenic headache) the pain drawing seems applicable as a screening tool for signs associated with neuropathic and more severe pain, dizziness and reduced quality of life as detection of these symptoms is essential for targeted treatment.
© 2022 Bernhoff et al.

Entities:  

Keywords:  chronic pain; primary health care; questionnaire; spine; symptom assessment

Year:  2022        PMID: 36061488      PMCID: PMC9432569          DOI: 10.2147/JPR.S369470

Source DB:  PubMed          Journal:  J Pain Res        ISSN: 1178-7090            Impact factor:   2.832


Introduction

The chronic fatigue syndrome (CFS), also referred to as myalgic encephalomyelitis (ME),1 is characterized by post-exertional malaise, severe fatigue and sleep disturbance, problems with thinking and concentration, as well as pain, headache and dizziness.2,3 These patients have reported their quality of life to be very low.4,5 Headache that is centered at the craniocervical junction can arise from diseases or disorders that involve any of the tissues in the neck such as muscles, ligaments, joints, nerves and bones. Cervicogenic headache is thought to be referred pain arising from irritation caused by cervical structures innervated by spinal nerves C1, C2, and C3; thus, any structure innervated by the C1–C3 spinal nerves could be the origin of cervicogenic headache.6,7 Such secondary cervicogenic headache radiates from the neck to the back of the head and may spread along the scalp to the forehead, temple and area around the ear and/or eye.8 Cervical findings have been linked to neurological symptoms among patients with ME/CFS9,10 and may give rise to persistent pain11 and headache12 along with impaired balance.13–15 Pain drawing is an important part of the clinical assessment to help determine whether the pain is neuropathic in nature, as this is assessed in a step model16 where a pain drawing is mandatory in step 1 (verifying whether the pain has a neuroanatomically plausible distribution). In a previous study on the use of pain drawing in headache diagnostics,17 the pain locality in patients with migraines was predominantly in the forehead and temples, while in cervicogenic headache usually suboccipitally, though sometimes overlapping.17 Pain drawing as a diagnostic measuring instrument is under development.18 A few studies have explored clinical applications with regard to the cervical spine, starting 2007, where the interrater reliability and between-session reliability was deemed adequate.19–24 Using pain pattern recognition to guide spinal level specific diagnostics has very limited evidence.22,25 Involvement of the second cervical nerve root, hereafter referred to as C2 involvement, however, may be identified by the corresponding characteristic pain pattern,17,26–31 and the sometimes-accompanying symptoms such as dizziness. Critical for the function of the balance system is input from the vast number of mechanoreceptors of the upper neck joints and surrounding soft tissues32–35 (informing of head movement versus trunk) mediated via C2.36,37 As the vestibular nuclei compose central vestibular outputs on the grounds of information from mechanoreceptors, vestibular organs of the inner ear, and visual system, abnormal C2 input can give rise to distorted experience of movement or balance sense.38–41 Dizziness sometimes accompanies neck pain or related disorders42 but pain in the upper neck can nonetheless occur without comorbidity of dizziness. Therefore, the assessment of patients with this type of symptoms would most likely benefit from screening with pain drawing along with balance measures. Determining the most plausible pain mechanisms is essential as this can serve as a guide in selecting the most appropriate treatment. The aim with this study was to (1) evaluate the significance of pain drawing as a screening tool for cervicogenic headache using a predefined C2 pain pattern, (2) assess whether there was an association between dizziness/imbalance and a C2 pain pattern, and (3) compare subgroups according to the pain drawing with respect to pain characteristics and quality of life.

Materials and Methods

This single-center non-experimental cross-sectional correlational study was conducted at a private, publicly funded specialist clinic for ME/CFS where patients with persistent fatigue from all of Sweden are investigated. All study participants were referred from primary care physicians. Recommendations for referral were based on: If specialist medical care was necessary, if rehabilitation with a team-based approach was considered necessary, or in cases of unresolved diagnostics after initial management in primary healthcare.

Participants

Participants were recruited to a cross-sectional research project aiming to improve the investigation of patients with persistent pain and fatigue. All adults (≥18 years) with suspected ME/CFS who gave their written informed consent to participate in the project were consecutively enrolled from February 2019 to March 2020. Inclusion criteria were I) severe fatigue affecting physical and/or mental functioning for a minimum of 3 months; and II) being admitted for investigation at the specialist clinic. Exclusion criteria were I) any clinical condition judged not to be compatible with following the investigation, eg, known alcohol or drug abuse, severe psychiatric symptoms (comorbidity, previous surgical treatment allowed) and; II) barriers to communicating in English or Swedish. The entire project population (n = 278) was engaged in the present study, inferring some redundancy of data as the statistical requirements for this analysis were approximately 100 participants, based on a prevalence of C2 involvement of about 15% among study participants (prevalence of cervicogenic headache in the general population 2–10% (Denmark, Norway, USA)43,44 and approximately 3 times more common among patients at the recruiting clinic, ie, 6–30%); and a confidence interval of 95%.45 This study was conducted in accordance with the Helsinki Declaration.46 All inclusion of patients’ data was approved by the Swedish Ethical Review Authority (2018/1754).

Data Collection

Data was collected prior to (mailed surveys) and during the first visits to the clinic. The pain drawing was included in a set of questionnaires used to report to the National Quality Registry for Pain Rehabilitation (NRS).

Outcome Variables

Headache

Was assessed with the paper pain drawing (the patient’s same drawing used for body pain extent, below) that has two silhouettes depicting the human body (frontal and dorsal view) (Figure 1).23 Markings in any part of the head, including the scalp and face was interpreted as headache. The drawing had an instruction that indicated the past three months and read to, “shade in pencil all areas where you have had discomfort”. Patients were also asked if appropriate to indicate next to the figure pain descriptors common in neuropathic pain,47 for example, “pins and needles” or “dull pain”. Pain descriptors, marks outside the silhouette or marks made to direct attention to pain characteristics were not noted in the assessment.
Figure 1

Pain drawing for headache assessment and body pain extent score.

Pain drawing for headache assessment and body pain extent score. To address the research aim, a standardized screening key was defined to identify a C2 pain pattern26,48–50 (Figure 2). An identified C2 pain pattern meant that both criteria A and B were met. Criterion B was met if one locality had been marked, or two or more in combination. Criteria A and B must be on the same side (right/left). In cases where the entire silhouette was filled out, side of the face must have a marking. If in dorsal view the entire head had been filled out, the lower half of the head must be in a darker shade (indicating increased pain intensity). The drawings were screened by a medical nurse independent of the project and one of the researchers (GB). In the event of disagreement in interpretation (yes/no), a joint reassessment was made to reach consensus. Patients were stratified according to the pain drawing into three subgroups: 1) cervicogenic headache as determined by markings on the pain drawing corresponding to a C2 pain pattern, 2) headache with no C2 pain pattern, and 3) no headache.
Figure 2

Standardized C2 pattern pain drawing key.

Standardized C2 pattern pain drawing key.

Pain Intensity

Patients reported their current pain intensity with a paper version of the 100 mm visual analogue scale (VAS): endpoints 0 = “no pain” and 100 = “worst possible pain”.51 The instruction read, “How much pain are you experiencing at this moment? (Please mark with an X on the line)”.

Body Pain Extent

It was assessed with the paper pain drawing (the patient’s same drawing used for headache, above), using the body region method by Margolis,52 where the drawing is divided into 45 anatomical regions. Each region is assigned a percent surface area, aggregated into a sum score 0–100%.

Dizziness/Imbalance

Verbally reported dizziness or imbalance53 by the patient at the first visit to the physician was assessed from the patients’ medical record. Dizziness or imbalance was logged as present regardless of phrasing by the attending physician. Examples of record entries (four different physicians): “All along he has had […] and balance issues”, “In addition, dizziness.”, “Bouts of dizziness.”, and “Sometimes when she experiences […] her gait tends to become wide.”.

Health-Related Quality of Life

Self-reported current health status was assessed with a paper version of the Euroqol 100 mm vertical VAS (EQ-VAS) with the endpoints 0 = “worst imaginable health” and 100 = “best imaginable health”.54

Data Analyses

Descriptive data were analyzed using non-parametric statistics due to the non-normal distribution of data. Interval data was handled as inherently ordinal variables.55 To avoid possible bias from excluding all cases where values were missing, we used MICE56 with 10 imputations using predictive mean matching for creating the VAS replacement data. For EQ-VAS, stochastic regression imputation was used.56 Binomial logistic regression57 was used to analyze association between the dependent variable dizziness/imbalance (yes/no) and the independent variables pain pattern (categorized), pain intensity (continuous) and body pain extent (continuous) and covariates age (19–59 years/≥60 years) and gender, presented with odds ratio (OR) and 95% confidence intervals (95% CI). The significance of the differences between subgroups as evaluated with pain drawings (above) was determined by Kruskal–Wallis tests.58 Level of significance was set to p < 0.05. All data analysis was performed in R version 4.1.1 (2021–08-10) Copyright ©2021 The R Foundation for Statistical Computing.59

Results

Over a period of 13 months (February 2019–March 2020), 278 subjects agreed to participate in the study. Three cases where study participants had refrained from symptom-reporting with the pain drawing were excluded from the analysis. For the remaining 275 participants, missing data consisted of 30 reports (11%) of self-rated quality of life, and 4 reports of pain intensity (1,5%). An overview of participants’ characteristics is presented in Table 1.
Table 1

Characteristics of the Study Participants (n = 275)

Gender (men/women) n (%)48/227 (17/83)
Age (years) median (IQR)46 (37–54)
Dizziness/imbalance (yes/no) (%)69/206 (25/75)
Pain intensity, VAS (mm) median (IQR)53 (34–72)
Body pain extent (%) median (IQR)51 (28–68)
Health-related quality of life, EQ-VAS (mm) median (IQR)30 (20–40)

Abbreviations: EQ-VAS, Euroqol vertical visual analogue scale; IQR, Interquartile range; VAS, Visual analogue scale.

Characteristics of the Study Participants (n = 275) Abbreviations: EQ-VAS, Euroqol vertical visual analogue scale; IQR, Interquartile range; VAS, Visual analogue scale. Each of the 275 drawings had a unique marking distributed over the figure. Drawings with the largest pain extent included all body quadrants and the axial area, and some drawings were blank. The assessors were in agreement for 96% of drawings in their interpretation by means of the standardized C2 pattern pain drawing key (yes/no). For 12 drawings, there was a renewed joint assessment by discussion until consensus was reached. Of all participants, 116 (42%) had markings in the pain drawing that corresponded to the specific C2 pain pattern (Figure 3).
Figure 3

Drawings from study participants. To the left (1–3) are examples where C2 involvement was assessed to be present. To the right (5–6) are drawings with examples of a negative outcome. (1) Criterion A is met (upper neck) and 3 of criteria B (pain involving back of head, both jaws and left temple). (2) Criterion A is met and 1 of criteria B: back of head. (3) Criterion A is met and 2 of criteria B: ear and jaw. (4) Criterion A is met, not B. (5) Criterion A is met, not B. (6) Neither A or B is met (homogenous shading, ie, no pain punctum maximum in C2 supplied areas).

Drawings from study participants. To the left (1–3) are examples where C2 involvement was assessed to be present. To the right (5–6) are drawings with examples of a negative outcome. (1) Criterion A is met (upper neck) and 3 of criteria B (pain involving back of head, both jaws and left temple). (2) Criterion A is met and 1 of criteria B: back of head. (3) Criterion A is met and 2 of criteria B: ear and jaw. (4) Criterion A is met, not B. (5) Criterion A is met, not B. (6) Neither A or B is met (homogenous shading, ie, no pain punctum maximum in C2 supplied areas). The proportion of patients in the total population who reported having dizziness or imbalance was 25%. Consequently, the remaining 75% did not report dizziness/imbalance in the initial consultation. There was a strong association between dizziness/imbalance and a C2 pattern, as compared to the group with no headache: OR 6.50 (95% CI 2.42–17.40, p-value: 0.00), and to the group with headache without the C2 pain pattern: OR 3.15 (95% CI 1.54–6.41, p-value: 0.00) (Table 2). There was no difference between men and women (p > 0.05), and no effect of any of the parameters age, pain intensity and body pain extent (p > 0.05). In the case of headaches without C2 pain patterns, the odds for dizziness were shown to be higher than for patients whose drawings indicated no headache, although a difference within the margin of error (not statistically significant).
Table 2

Logistic Regression of Associations Between Having Dizziness/Imbalance and Headaches Among Patients in Investigation for Possible ME/CFS

Explanatory VariablesUnadjusted OR (95% CI)Adjusted OR (95% CI)p-value (Adjusted)
C2 pain pattern*8.17 (3.28–20.55)6.50 (2.42–17.40)0.00
C2 pain pattern**3.76 (1.90–7.43)3.15 (1.54–6.41)0.00
Headache (no C2 pain pattern)*2.17 (0.79–5.98)2.13 (0.74–6.14)0.16
Pain intensity1.01 (0.99–1.02)0.21
Body pain extent1.00 (0.99–1.02)0.52
Women0.70 (0.31–1.61)0.40
Age ≥60 years1.20 (0.50–2.89)0.68

Notes: Reference groups: *No headache n = 73. **Headache with no C2 pain pattern n = 86.

Logistic Regression of Associations Between Having Dizziness/Imbalance and Headaches Among Patients in Investigation for Possible ME/CFS Notes: Reference groups: *No headache n = 73. **Headache with no C2 pain pattern n = 86. Table 3 presents the differences between the three pain pattern subgroups. These results showed that the outcomes with respect to pain and quality of life differed significantly depending on the subgroup (p < 0.05). The group that presented with the pre-defined C2 pattern had higher pain intensity (VAS median 66.5 mm, range 49.0–79.0), and more vast body pain extent (61.4%, range 44.6–76.3), than the other groups. Consistently, the group that presented with a C2 pattern in pain drawing had significantly lower self-rated quality of life (EQ-VAS median 26.5 mm, range 20.0–38.3) than those who presented with no headache according to the pain drawing (p = 0.00).
Table 3

Comparison Between Scores of Pain and Health-Related Quality of Life of the Three Subgroups Based on the Pain Drawing

Patient Reported Outcomes1 Headache with C2 Pain Pattern n = 1162 Headache (no C2 Pain Pattern) n = 863 No Headachen = 73P-value (Between Groups)
Pain intensity, VAS (0–100 mm) Median (IQR)66.50 (49.00–79.00)48.50 (31.00–65.25)40.00 (19.00–57.00)1–2 0.002–3 0.07
Body pain extent (0–100%) Median (IQR)61.38 (44.62–76.31)46.25 (28.19–64.31)31.50 (15.50–51.00)1–2 0.002–3 0.00
Health-related quality of life, EQ-VAS (0–100 mm) Median (IQR)26.50 (20.00–38.25)30.00 (20.00–40.00)35.00 (25.00–50.00)1–2 0.072–3 0.04

Notes: BPE, body pain extent; EQ-VAS, Euroqol vertical visual analogue scale; IQR, inter-quartile range; VAS, visual analogue scale.

Comparison Between Scores of Pain and Health-Related Quality of Life of the Three Subgroups Based on the Pain Drawing Notes: BPE, body pain extent; EQ-VAS, Euroqol vertical visual analogue scale; IQR, inter-quartile range; VAS, visual analogue scale.

Discussion

The findings demonstrated that a C2 pattern (putative cervicogenic headache) as determined by pain drawing was common among patients with chronic fatigue. Complaints of dizziness/imbalance were more prevalent in this group as compared to patients without a C2 pain pattern. Besides, self-reported pain was worse in patients who did present with the C2 pain pattern. The results thus imply that there might be a cervical spinal nerve involvement in patients with chronic fatigue who present with cervicogenic headache. Similar findings have been reported previously.10,60 Lindal et al60 studied common pain localities in a group of women with CFS after many years of illness, and found neck pain to be the most common site. Rowe et al10 studied surgical treatment for three patients diagnosed with severe ME/CFS and concluded that cervical stenosis could be part of the pathogenesis of ME/CFS. Studies have also shown a link between central sensitization and persistent symptoms after a neck injury.61,62 Central sensitization includes increased pain sensitivity and generalized pain.63 This was paralleled in the present study, in that measures that were rated high among patients (pain intensity and body pain extent), were associated with self-reported cervical symptoms, suggestive of the C2 pain pattern reflecting or indicating a condition in the upper neck. The link between dizziness/imbalance and cervicogenic headache, the latter in this study measured as a C2 pattern with a pain drawing, is in agreement with earlier research,64 including whiplash-associated disorders65 as well as ME/CFS:9,66 Serrador et al66 found impaired balance in standing to be present in CFS (27 patients compared with 22 matched controls). They also found that a decreased vestibular function occurred with a comorbidity of fibromyalgia.66 A hallmark of fibromyalgia is central sensitization.67 Thus, in theory, the covariation in the study by Serrador et al66 between imbalance and a worse degree of pain seems to have been in harmony with our results. No firm conclusions can however be drawn from such extrapolation. Matsui et al9 evaluated treatment of cervical musculature in ME/CFS through low-frequency electrical stimulation and far-infrared irradiation. The greatest effect was achieved in relation to vertigo or dizziness, nausea or stomachache, and depression (recovery rate more than 70%). Their results have clear points of contact with the present study in that the neck had significance for the health status and that there was a covariation between neck and dizziness. Gustavsen et al42 studied associations between musculoskeletal pain, dizziness and health-related quality of life, with pain as the dependent variable. They found that musculoskeletal pain was associated with increasing dizziness, and the combination of neck pain and dizziness was proposed as a possible trigger of persistent postural-perceptual dizziness (PPPD).68 PPPD is classified as a chronic vestibular disorder,68 but because no structural abnormality has yet been identified, it is so far called functional, ie, the vestibular system operates irregularly although we do not know why. A painful abnormality of the joint capsules and deep muscles at the craniocervical junction might indeed disrupt the normal functions of the central vestibular system, as it combines not only vestibular and visual but also somatosensory signals from all muscles and joints and foremost of all the upper neck.69 Quality of life was shown to be worse for the group with headaches and a C2 pattern than for the group without headache. This is in line with previous research of negative effects on perceived health from headache70 as well as from dizziness, and where patients found the impaired function to be an important factor, rather than emotional aspects.71,72 Using pain drawing to examine patients with chronic fatigue has been investigated in some previous studies. Lindal et al60 studied common pain localities in CFS with the same method used in the present study for the assessment of body pain extent, to divide the pain drawing into 45 body regions.52 No pain in the suboccipital area was however found in the study by Lindal et al.60 Though not mentioned by the authors, about 30% had reported headache, although in the two regions, each representing the entire half side of the head in frontal view, thus providing an unspecified description of headaches (unknown whether a marking referred to the forehead, temple or jaw, etc.).60 Another small case study (12 patients with fibromyalgia)73 studied pain treatment by means of pain drawing (counting painful body regions and measuring total painful area with the help of a grid). However, specifics about the outcomes were not reported. There are challenges in studying the usefulness of new interpretations of pain drawing with properties that aim to aid in the screening of patients. The drawings used in research often have different designs, why results can be limited to the study context, rather than contributing to a refinement of standard drawing design. This limits the usefulness of historical comparisons. However, to evaluate modes of interpretation which can be applied successfully regardless of the drawing’s design is very valuable as was done in our study. A strength with the present study is that the variable for dizziness was free from attention-induced bias. We chose not to include data from the patient pre-admission questionnaire for the Canadian Consensus Criteria, section for autonomous manifestations (“Dizziness and/or lightheadedness”)74 likely to have low content validity. If checklists are used to gather information from patients, bias can come from some psychosocial events, shown for example for symptom reporting after concussions.75 Mechanisms are believed to be that expectations become etiology, a tendency to overestimate your good health earlier in life, and to exaggerate symptoms.75 Some studies support spontaneously reported symptoms as a reliable source of information, representing a more sensitive index of patients’ actual problems than can be obtained from structured surveys.76,77 It is unknown whether attention-induced bias appeared regarding the VAS, pain drawing and EQ-VAS instruments. It is conceivable that the pain drawing could be favored (comparatively lower degree of attention-induced bias) due to the relatively open-ended instruction of how to fill out the drawing. Moreover, option to compare the epidemiology of ME/CFS across studies is limited since the diagnostic criteria used vary,78 but the study population was representative in terms of age range (ME/CFS most common between 40 and 60 years) and gender distribution (about 80% women) according to the Centers for Disease Control and Prevention.2 The study’s limitations were that the data derived from medical records were logged by several physicians where quality and accuracy were likely to vary, and it cannot be ruled out that dizziness/imbalance existed in more patients but did not emerge. The study group had been investigated within the primary health-care system prior to being referred to the specialist clinic, and thus asked to join the study, which implies that other causes of dizziness/imbalance had been excluded (other than a cervicogenic cause), but no action was taken in the study to verify the reported symptoms using a more objective measurement method, which would be needed to assess any under- or overreporting. Generalization of results must therefore be made with caution. The confidence interval showed a wide range for the actual odds ratio of the entire population of interest to fall within, an effect of the relative occurrence of events within the sample. A more extensive sample size with a nearer to normal distribution of the sample odds ratios would improve precision. Despite the result being imprecise, it has clinical value, and suggests that a pain drawing in a straightforward and manageable test can be used for mapping parts of the nature and the severity of conditions. It can be one way to increase the effectiveness in the investigation of people who have persistent non-malignant pain. The association shown here between dizziness/imbalance and the C2 pain pattern is supportive to a limited degree of the C2 pain pattern being condition specific and thereby potentially valuable as a complementary tool for understanding the pathophysiology of headaches and associated disorders.

Conclusion

For patients with chronic fatigue who present with a C2 pain pattern (interpreted as cervicogenic headache) the pain drawing seems applicable as a screening tool for signs associated with neuropathic and more severe pain, dizziness and reduced quality of life as detection of these symptoms is essential for targeted treatment.
  72 in total

1.  Muscle spindle distribution, morphology, and density in longus colli and multifidus muscles of the cervical spine.

Authors:  L C Boyd-Clark; C A Briggs; M P Galea
Journal:  Spine (Phila Pa 1976)       Date:  2002-04-01       Impact factor: 3.468

2.  The localization of pain in chronic fatigue syndrome on a pain drawing according to grid areas.

Authors:  E Líndal; S Bergmann; S Thorlacius; J G Stefánsson
Journal:  Percept Mot Skills       Date:  1996-10

3.  Mechanoreceptor endings in human cervical facet joints.

Authors:  R F McLain
Journal:  Spine (Phila Pa 1976)       Date:  1994-03-01       Impact factor: 3.468

4.  Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale.

Authors:  Anna Maria Carlsson
Journal:  Pain       Date:  1983-05       Impact factor: 6.961

5.  Base rates of postconcussion syndrome by method of symptom report.

Authors:  Shannon L Edmed; Karen A Sullivan
Journal:  Appl Neuropsychol Adult       Date:  2012-05-22       Impact factor: 2.248

6.  Quality of life of patients with cervicogenic headache: a comparison with control subjects and patients with migraine or tension-type headache.

Authors:  Hans A van Suijlekom; Inge Lamé; Suzanne G M Stomp-van den Berg; Alfons G H Kessels; Wilhelm E J Weber
Journal:  Headache       Date:  2003 Nov-Dec       Impact factor: 5.887

7.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

8.  The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).

Authors:  Michael Falk Hvidberg; Louise Schouborg Brinth; Anne V Olesen; Karin D Petersen; Lars Ehlers
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 9.  Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.

Authors:  Fernando Estévez-López; Kathleen Mudie; Xia Wang-Steverding; Inger Johanne Bakken; Andrejs Ivanovs; Jesús Castro-Marrero; Luis Nacul; Jose Alegre; Paweł Zalewski; Joanna Słomko; Elin Bolle Strand; Derek Pheby; Evelina Shikova; Lorenzo Lorusso; Enrica Capelli; Slobodan Sekulic; Carmen Scheibenbogen; Nuno Sepúlveda; Modra Murovska; Eliana Lacerda
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

10.  Possible involvement of the autonomic nervous system in cervical muscles of patients with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS).

Authors:  Takayoshi Matsui; Kazuhiro Hara; Makoto Iwata; Shuntaro Hojo; Nobuyuki Shitara; Yuzo Endo; Hideoki Fukuoka; Masaki Matsui; Hiroshi Kawaguchi
Journal:  BMC Musculoskelet Disord       Date:  2021-05-05       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.